Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Zydus Cadila gets tentative US approval for iron excess drug

      Zydus Cadila gets tentative US approval for iron excess drug

      Ruby Khatun Khatun9 July 2018 10:30 AM IST
      New Delhi: Drug firm Zydus Cadila said it has got a tentative nod from the US health regulator to market Deferasirox tablets for oral...
      UKs unsafe syringes found their way to Indian hospitals: Report

      UK's unsafe syringes found their way to Indian hospitals: Report

      Ruby Khatun Khatun9 July 2018 10:26 AM IST
      LONDON: Syringes declared unsafe for use by the UK's state-funded National Health Service (NHS) found their way to India and are likely to have been...
      Pharma sector may post 17 percent revenue growth in June quarter: Report

      Pharma sector may post 17 percent revenue growth in June quarter: Report

      Ruby Khatun Khatun9 July 2018 10:00 AM IST
      MUMBAI: The pharmaceutical industry is likely to report a 17 percent revenue growth in the June quarter, driven by strong domestic growth and currency...
      Chinese film on cancer patients plight highlights urgent need for import of Indian drugs

      Chinese film on cancer patient's plight highlights urgent need for import of Indian drugs

      Ruby Khatun Khatun9 July 2018 9:45 AM IST
      Beijing: A Chinese film on the plight of a leukaemia patient highlights the pressing need for China to pave the way for import of Indian cancer drugs,...
      Hitting cancer early: AstraZenecas bid to outmaneuver rivals

      Hitting cancer early: AstraZeneca's bid to outmaneuver rivals

      Ruby Khatun Khatun9 July 2018 9:30 AM IST
      LONDON: AstraZeneca suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief...
      Trace and Track: Drug authentication system to be applicable on 300 brands

      Trace and Track: Drug authentication system to be applicable on 300 brands

      Ruby Khatun Khatun8 July 2018 12:50 PM IST
      INDORE: The proposed process of authentication and the Trace and Track mechanism of drugs to curb counterfeit and spurious medicines is going to be...
      Fortis board can’t determine if fraud happened, auditor says: Report

      Fortis board can’t determine if fraud happened, auditor says: Report

      Ruby Khatun Khatun8 July 2018 11:00 AM IST
      The auditor of Fortis Healthcare Ltd. said the company’s board has been unable to determine if a fraud was committed after an investigation found...
      Dr Reddys bullish about better sales in Europe in FY19

      Dr Reddys bullish about better sales in Europe in FY19

      Ruby Khatun Khatun8 July 2018 10:30 AM IST
      New Delhi: Dr Reddys Laboratories expressed hope of higher sales this year in Europe, a key market, as it has overcome some of the regulatory issues...
      CSIR-IMTECH inks pact with Zydus Cadila

      CSIR-IMTECH inks pact with Zydus Cadila

      Ruby Khatun Khatun8 July 2018 10:15 AM IST
      New Delhi: Drug firm Zydus Cadila said it has inked an agreement with Council of Scientific and Industrial Research (CSIR) - Institute of Microbial...
      Lupin foundation aims to make 3 districts poverty free by 2022

      Lupin foundation aims to make 3 districts poverty free by 2022

      Ruby Khatun Khatun8 July 2018 10:00 AM IST
      Sindhudurg: Lupin Foundation, the CSR arm of pharma company Lupin Ltd, said it will adopt three districts -- one each in Rajasthan, Maharashtra and...
      Infosys partners with Siemens to develop advanced IoT solutions

      Infosys partners with Siemens to develop advanced IoT solutions

      Ruby Khatun Khatun8 July 2018 9:45 AM IST
      New Delhi: IT major Infosys unveiled a new partnership with Siemens PLM Software to develop applications and services for MindSphere, the open...
      Unsealed lawsuit: Opioid firm placed profits over people

      Unsealed lawsuit: Opioid firm placed profits over people

      Ruby Khatun Khatun8 July 2018 9:30 AM IST
      NASHVILLE, Tenn.: A newly unsealed lawsuit by Tennessee's attorney general says the maker of the world's top-selling painkiller directed its sales...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok